Journal of Pancreatic Cancer
Overview
Journal of Pancreatic Cancer is a scientific journal, published since 2017 in English. The journal's country of origin is United States.
Details
Details
Recent Articles
11.
McGhee-Jez A, Chervoneva I, Yi M, Ahuja A, Nahar R, Shah S, et al.
J Pancreat Cancer
. 2021 Jun;
7(1):23-30.
PMID: 34095739
Current literature reports increased incidence of postpancreaticoduodenectomy (PD) nonalcoholic fatty liver disease (NAFLD), a precursor for nonalcoholic steatohepatitis and cirrhosis. The incidence of and risk factors (RFs) for NAFLD in...
12.
Ries R, Jacovides C, Rashti J, Gong J, Yeo C
J Pancreat Cancer
. 2021 Jun;
7(1):20-22.
PMID: 34095738
Both primary pancreatic lymphoma (PPL) and primary splenic lymphoma (PSL) represent rare entities. PPL typically arises in the head of the pancreas but may arise in other locations also. PSL...
13.
Vining C, Hsu P, Schuitevoerder D, Joseph N, Hogg M
J Pancreat Cancer
. 2021 Jun;
6(1):96-101.
PMID: 34095737
Liver parenchyma that resides outside of the normal hepatic confines is defined as accessory liver if in communication with the native biliary tree, or ectopic liver (EL) if it is...
14.
Hue J, Bingmer K, Sugumar K, Markt S, Rothermel L, Hardacre J, et al.
J Pancreat Cancer
. 2021 May;
7(1):31-38.
PMID: 33937617
Immunotherapy (IT) has led to improved survival in several common cancers but success in pancreatic ductal adenocarcinoma (PDAC) has been limited. We analyzed if combination IT-chemotherapy (IT-CT) is associated with...
15.
Muscarella P, Bekaii-Saab T, McIntyre K, Rosemurgy A, Ross S, Richards D, et al.
J Pancreat Cancer
. 2021 Mar;
7(1):8-19.
PMID: 33786412
GI-4000, a series of recombinant yeast expressing four different mutated RAS proteins, was evaluated in subjects with resected -mutated pancreas cancer. Subjects ( = 176) received GI-4000 or placebo plus...
16.
Campbell D, Isch E, Kozak G, Yeo C
J Pancreat Cancer
. 2021 Feb;
7(1):1-7.
PMID: 33569523
Primary pancreatic signet ring cell carcinoma (PPSRCC) is a rare (<1%) poorly reported histopathological variant of pancreatic cancer with ill-defined treatment guidelines. Herein, we describe a case of nonmetastatic PPSRCC...
17.
Appelbaum R, Kuehler D, Brodsky J
J Pancreat Cancer
. 2020 Dec;
6(1):116-118.
PMID: 33376938
As treatment of esophageal carcinomas continues to improve, we have seen an increasing population of long-term survivors giving rise to the observation of additional primary malignancies not previously seen. Esophagogastrectomy...
18.
Kasi A, Al-Jumayli M, Park R, Baranda J, Sun W
J Pancreat Cancer
. 2020 Dec;
6(1):107-115.
PMID: 33376937
Pancreatic ductal adenocarcinoma (PDAC) is the most common cancer found in the pancreas. It has a dismal prognosis and current therapeutic options, including surgical resection, provide only a temporary or...
19.
King D, Pineda G, Jhun I, Fisher G
J Pancreat Cancer
. 2020 Dec;
6(1):102-106.
PMID: 33269335
The CA 19-9 tumor marker is commonly used alongside imaging to trend chemotherapy response in patients with pancreatic ductal adenocarcinoma. We describe an unusual clinical case of metastatic pancreatic cancer...
20.
Watson M, Miller-Ocuin J, Driedger M, Beckman M, McKillop I, Baker E, et al.
J Pancreat Cancer
. 2020 Oct;
6(1):85-95.
PMID: 32999955
Underutilization of operative management of early stage pancreatic cancer is associated with sociodemographic variables, including age, race, facility type, insurance, and education. It is currently unclear how these variables are...